ReviewFrontiers in oncology2024

EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma.

Robert C Sterner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.